Short answer
ACME UNITED CORP (ACU) filed an 8-K current report with the SEC on April 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 results for quarter ended March 31, 2026.
ACME UNITED CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 31, 2026
- Financial details and management commentary available in Exhibit 99.1 press release
Item EX-99.1 · Exhibit EX-99.1
- Q1 2026 sales rose 14% to $52.3M, with 6% comparable growth excluding My Medic
- Net income fell 40% to $1.0M and diluted EPS 41% to $0.24 amid tariffs, healthcare costs, and Med-Nap investments
- Gross margin improved to 39.7% from 39.0%, but SG&A increased to $19.0M from $15.5M
- My Medic contributed minimal Q1 earnings, with most profitability expected in Q4 due to seasonal direct-to-consumer demand
- Net debt rose to $38.6M, while approximately $10M of incremental inventory orders target anticipated Iran-related shortages and cost increases
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACME UNITED CORP 8-K filings
Get the next ACU 8-K as it lands
Follow ACU for push alerts, or ask the research agent what this filing means.